EMAP-II facilitates TNF-R1 apoptotic signalling in endothelial cells and induces TRADD mobilization

Apoptosis

Volumn 11, Issue 12, 2006, Pages 2137-2145

  Horssen, Remco Van ^a,b   Rens, Joost A P ^a   Schipper, Debby ^a   Eggermont, Alexander M M ^a   Hagen, Timo L M Ten ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; EMAP II; Endothelial cells; TNF R1; TRADD

Indexed keywords

CYTOKINE; DEATH RECEPTOR; ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE II; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED DEATH DOMAIN PROTEIN;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENDOTHELIUM CELL; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL MEMBRANE; CELLS, CULTURED; CYTOKINES; ENDOTHELIAL CELLS; HUMANS; NEOPLASM PROTEINS; PROTEIN TRANSPORT; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED DEATH DOMAIN PROTEIN; TRANSPORT VESICLES;

EID: 33845371903     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-0284-5     Document Type: Article

References (24)

1. Murray JC, Clauss M, Denekamp J, Stern D (1991) Selective induction of endothelial cell tissue factor in the presence of a tumour-derived mediator: a potential mechanism of flavone acetic acid action in tumour vasculature. Int J Cancer 49:254-259
2. Kao J, Ryan J, Brett G et al (1992) Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms. J Biol Chem 267:20239-20247
3. Schwarz MA, Kandel J, Brett J et al (1999) Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells. J Exp Med 190:341-354
4. Chang SY, Ko HJ, Heo TH, Kang CY (2005) Heparan sulfate regulates the antiangiogenic activity of endothelial monocyte-activating polypeptide-II at acidic pH. Mol Pharmacol 67:1534-1543
5. Schwarz MA, Zheng H, Liu J, Corbett S, Schwarz RE (2005) Endothelial-monocyte activating polypeptide II alters fibronectin based endothelial cell adhesion and matrix assembly via alpha5 beta1 integrin. Exp.Cell Res 311:229-239
6. Murray JC, Symonds P, Ward W et al (2004) Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II- dependent mechanism. J Immunol 172:274-281
7. Wu PC, Alexander HR, Huang J et al (1999) In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-alpha is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII). Cancer Res 59:205-12
8. Gnant MF, Berger AC, Huang J et al (1999) Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus. Cancer Res 59:4668-4674
9. Lans TE, ten Hagen TL, Van Horssen R et al (2002) Improved antitumor response to isolated limb perfusion with tumor necrosis factor after upregulation of endothelial monocyte-activating polypeptide II in soft tissue sarcoma. Annals Surg Oncol 9:812-819
10. Berger AC, Alexander HR, Wu PC et al (2000) Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte-activating polypeptide II (EMAP-II). Cytokine 12:992-1000
11. Tandle AT, Mazzanti C, Alexander HR, Roberts DD, Libutti SK (2005) Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells. Cytokine 30:347-358
12. Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281:1305-1308
13. Tartaglia LA, Goeddel DV (1992) Two TNF receptors. Immunol Today 13:151-153
14. Jones SJ, Ledgerwood EC, Prins JB et al (1999) TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1. J Immunol 162:1042-1048
15. Baud V, Karin M (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11:372-377
16. Micheau O, Tschopp J (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114:181-190
17. Schneider-Brachert W, Tchikov V, Neumeyer J et al (2004) Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21:415-428
18. Harper N, Hughes M, MacFarlane M, Cohen GM (2003) Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. J Biol Chem 278:25534-25541
19. Eggermont AM, de Wilt JH, ten Hagen TL (2003) Current uses of isolated limb perfusion in the clinic and a model system for new strategies. Lancet Oncol 4:429-437
20. Lejeune FJ, Lienard D, Eggermont AMM et al (1994) Rationale for using TNF alpha and chemotherapy in regional therapy of melanoma. J Cell Biochem 56:52-61
21. Van Horssen R, Rens JAP, Brunstein F et al (2006) Intratumoural expression of TNF-R1 and EMAP-II in relation to response of patients treated with TNF-based isolated limb perfusion. Int J Cancer 119:1481-1490
22. Berger AC, Alexander HR, Tang G et al (2000) Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis. Microvasc Res 60:70-80
23. Stoelcker B, Ruhland B, Hehlgans T, Bluethmann H, Luther T, Mannel DN (2000) Tumor necrosis factor induces tumor necrosis via tumor necrosis factor receptor type 1-expressing endothelial cells of the tumor vasculature. Am J Pathol 156:1171-1176
24. Li X, Minden A (2005) Pak4 functions in TNFalpha induced survival pathways by facilitating TRADD binding to the TNF receptor. J Biol Chem 280:41192-41200